Researchers from the HIV Prevention Trials Community (HPTN) offered outcomes from HPTN 091 (“I Am Research”) on the HIVR4P 2024 convention in Lima, Peru. The research examined the acceptability and feasibility of an built-in, multicomponent technique to enhance day by day uptake and adherence to oral HIV pre-exposure prophylaxis (PrEP) in transgender girls in a […]